• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bruise/Contusion (1754); Phlebitis (2004); Skin Discoloration (2074); Paresthesia (4421); Insufficient Information (4580)
Event Date 08/11/2021
Event Type  Injury  
Event Description
A journal article was submitted detailing a study to assess the effects of endovenous laser ablation (evla), radiofrequency ablation (rfa), endovenous steam ablation (evsa), ultrasound-guided foam sclerotherapy (ugfs), cyanoacrylate glue, mechanochemical ablation (moca) and high ligation and stripping (hl/s) for the treatment of varicosities of the great saphenous vein (gsv).Technical failure was defined as "an open refluxing segment of 10cm or more at follow up" reported in both groups.Complications reported for rfa treatment included pain, hematoma, saphenous nerve injury (paraesthesia), thermal injury or inflammation (skin burn and phlebitis), wound problems (groin/ stab), bruising and pigmentation, skin staining, pulmonary embolism,dvt, ehit and phlebitis from the included studies.Minor complications reported for ca treatment included saphenous nerve injury, bruising and pigmentation, and chronic phlebitis from the included studies.Wound problems requiring intervention are reported for rfa and ca.
 
Manufacturer Narrative
Title: interventions for great saphenous vein incompetence (review) author: whing j, nandhra s, nesbitt c, stansby g journal: cochrane database of systematic reviews year: 2021 vol/issue: 8 ref: 10.1002/14651858.Cd005624.Pub4.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key13635763
MDR Text Key286347520
Report Number9612164-2022-00832
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K111887
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-